The Mayo Clinic Manuscript Series Relative to the Discussion, Dissemination, and Operationalization of the Food and Drug Administration Guidance on Patient-Reported Outcomes
Article first published online: 8 NOV 2007
Value in Health
Special Issue: The FDA Guidance for Patient-Reported Outcomes
Volume 10, Issue Supplement s2, pages S59–S63, November/December 2007
How to Cite
Sloan, J. A., Halyard, M. Y., Frost, M. H., Dueck, A. C., Teschendorf, B., Rothman, M. L. and the Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group (2007), The Mayo Clinic Manuscript Series Relative to the Discussion, Dissemination, and Operationalization of the Food and Drug Administration Guidance on Patient-Reported Outcomes. Value in Health, 10: S59–S63. doi: 10.1111/j.1524-4733.2007.00267.x
- Issue published online: 8 NOV 2007
- Article first published online: 8 NOV 2007
- 1Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims (DRAFT). US Department of Health and Human Services Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER); Center for Devices and Radiological Health (CDRH), February 2006. Available from: http://www.fda.gov/cder/guidance/5460dft.htm[Accessed May 18, 2007].
- 5Incorporating the patient's perspective into drug development and communication: an Ad Hoc Task Force report on the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001. Value Health 2003;5:522–31., , , et al.
- 9Institute of Medicine. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Research Council of the National Academies, 2005.
- 11Making sense of quality-of-life data. Med Care 2000;38:II-175–9..
- 12Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge, UK: Cambridge University Press, 2005., , .